Introduction: Malaria during pregnancy is a major public health concern in most endemic areas, including Benin. To overcome this, the World Health Organization (WHO) recommends several prevention strategies, including the administration of sulfadoxine-pyrimethamine (SP) during pregnancy. Objective: To study the factors associated with low coverage of Intermittent Preventive Treatment with sulfadoxine-pyrimethamine (IPT-SP) against Malaria in pregnant women at Dassa-Glazoué area hospital in 2020. Study Method: This was a descriptive, analytical study with retrospective data collection that took place from May 25 to September 25, 2020. Results: During our study, three hundred and forty (340) pregnant women were investigated. The mean age was 27.67±6.12 years. The pregnant women included in the study were traders/dealers (35%) with a primary level of education (35%) and living in a common-law relationship (77.65%). The prevalence of IPT-SP coverage in antenatal care (ANC) was 35.00%. The number of ANC (less than 4) attended by the pregnant women (p=0.00), the age of more than 3 months from pregnancy to the first ANC (p=0.00) and non-compliance with ANC (p=0.00) were the factors associated with this low coverage. Conclusion: ANC is a special time for the administration of SP. New strategies must be put into place for the correct use of this service by pregnant women.
Published in | Journal of Gynecology and Obstetrics (Volume 9, Issue 6) |
DOI | 10.11648/j.jgo.20210906.12 |
Page(s) | 195-199 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Intermittent Preventive Treatment, Sulfadoxine-Pyrimetamine, Antenatal Consultation, Malaria
[1] | Ministry of Health of Benin. Strategic plan to fight against malaria 2011-2015: towards a malaria-free Benin. Cotonou (BEN): Ministry of Health; 2012: 100 p. |
[2] | World Health Organization (WHO). A strategic framework for malaria prevention and control during pregnancy in the African Region: Report AFR/MAL/04/0 Brazzaville. 2004. Geneva. Switzerland. WHO. PubMed Google Scholar. |
[3] | Tiendrebéogo J, Koiné Drabo M, Saizonou J, Soglohoun CT, Paraïso NM, Sié A, Ouedraogo LT, et al. Factors associated with the low coverage of intermittent preventive treatment among pregnant women in the Benin area hospital of pobè-adja-ouèrè-kétou, Public Health. 2015; 27 (1): 99-106. |
[4] | Roll Back Malaria. Efforts to prevent malaria in pregnancy save lives and improve maternal and newborn health [Online]. Jul 2014 [Accessed October 2, 2021]. Available at the URL: https://reliefweb.int/report/world/les-efforts-de-pr-vention-du-paludisme-pendant-la-grossesse-sauvent-des-vies-et-am. |
[5] | World Health Organization, Global Malaria Program. World malaria report 2017. 2017; p 196. |
[6] | WHO Intermittent preventive treatment for malaria in pregnancy with sulfadoxine-pyrimethamine ITP-SP. WHO Policy Guidance Document. [In line]. January 2014 [Accessed October 4, 2021]. Available at URL: https://www.afro.who.int/sites/default/files/2017-06/iptp-sp-updated-policy-brief-24jan2014-fr.pdf. |
[7] | INSAE. Fifth Demographic and Health Survey in Benin (EDSB-V) 2017-2018. [Online]. 2018 [Consulted on October 09, 2021]. Available at URL: https://www.afro.who.int/sites/default/files/2017-06/iptp-sp-updated-policy-brief-24jan2014-fr.pdf. |
[8] | Biaou COA, Kpozehouen A, Glèlè-Ahanhanzo Y, Ayivi-Vinz G, Ouro-Koura AR, Azandjèmé C. Intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women and effect on the baby's birth weight: application of the 3-dose policy in urban areas in South Benin in 2017, Pan African Medical Journal. 2019; 34: 155. doi: 10.11604/pamj.2019.34.155.19357. |
[9] | Sirima SB, Cotte AH, Konaté A, Moran AC, Asamoa K, Bougouma EC, et al. Malaria prevention during pregnancy: Assessing the disease burden one year after implementing a program of intermittent preventive treatment in koupéla district, Burkina Faso. Am J Trop Med Hyg. 2006; 75 (2): 205-11. PubMed | Google Scholar. |
[10] | Hommerich L, Von Oertzen C, Bedu-Addo G, Holmberg V, Acquah PA. Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy. Malar J. 2007; 6: 144. PubMed | Google Scholar. |
[11] | Kayentao K, Kodio M, Newman R, Maiga H, Doumtabe D, Ongoiba A et al. Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. J Infect Dis. 2005; 191: 109-116. Google Scholar. |
[12] | Bamba S, Séré A, Nikiéma R, Halidou T, Thiéba B, Dao B, et al. Intermittent preventive treatment with sulfadoxine – pyrimethamine for malaria in pregnant women: efficacy and compliance in two urban hospitals in Burkina Faso. Pan Afr Med J. 2013; 14: 105-13. doi: 10.11604/pamj.2013.14.105.1331. |
[13] | Bouyou-Akotet MK, Mawili-Mboumba DP, Kombila M. Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon. BMC Pregnancy Childbirth. 2013; 13 (1): 52. |
[14] | Pell C, Straus L, Andrew EV, Menaca A, Pool R. Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: a systematic review of the qualitative research. PLoS One. 2011; 6 (7): e22452. doi: 10.1371/journal.pone.0022452. |
[15] | Ndyomugyenyi R, Katamanywa J. Intermittent preventive treatment of malaria in pregnancy (IPT): do frequent antenatal care visits ensure access and compliance to IPT in Ugandan rural communities? Trans R Soc Trop Med Hyg. 2010; 104 (8): 536–40. |
[16] | Kisuule I, Kaye DK, Najjuka F, Ssematimba SK, Arinda A, Nakitende G, et al. Timing and reasons for coming late for the first antenatal care visit by pregnant women at Mulago hospital, Kampala Uganda. BMC Pregnancy Childbirth. 2013; 13 (1): 121-8. doi: 10.1186/1471-2393-13-121. |
APA Style
Atade Sèdjro Raoul, Ogoudjobi Ogourindé Mathieu, Dangbemey Djima Patrice, Djodi Salamatou, Klipezo Roger, et al. (2021). Factors Associated with Low Coverage of Intermittent Preventive Treatment with Sulfadoxyne-Pyrimethamine in Pregnancy in Dassa-Glazoué. Journal of Gynecology and Obstetrics, 9(6), 195-199. https://doi.org/10.11648/j.jgo.20210906.12
ACS Style
Atade Sèdjro Raoul; Ogoudjobi Ogourindé Mathieu; Dangbemey Djima Patrice; Djodi Salamatou; Klipezo Roger, et al. Factors Associated with Low Coverage of Intermittent Preventive Treatment with Sulfadoxyne-Pyrimethamine in Pregnancy in Dassa-Glazoué. J. Gynecol. Obstet. 2021, 9(6), 195-199. doi: 10.11648/j.jgo.20210906.12
AMA Style
Atade Sèdjro Raoul, Ogoudjobi Ogourindé Mathieu, Dangbemey Djima Patrice, Djodi Salamatou, Klipezo Roger, et al. Factors Associated with Low Coverage of Intermittent Preventive Treatment with Sulfadoxyne-Pyrimethamine in Pregnancy in Dassa-Glazoué. J Gynecol Obstet. 2021;9(6):195-199. doi: 10.11648/j.jgo.20210906.12
@article{10.11648/j.jgo.20210906.12, author = {Atade Sèdjro Raoul and Ogoudjobi Ogourindé Mathieu and Dangbemey Djima Patrice and Djodi Salamatou and Klipezo Roger and Salifou Kabibou}, title = {Factors Associated with Low Coverage of Intermittent Preventive Treatment with Sulfadoxyne-Pyrimethamine in Pregnancy in Dassa-Glazoué}, journal = {Journal of Gynecology and Obstetrics}, volume = {9}, number = {6}, pages = {195-199}, doi = {10.11648/j.jgo.20210906.12}, url = {https://doi.org/10.11648/j.jgo.20210906.12}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jgo.20210906.12}, abstract = {Introduction: Malaria during pregnancy is a major public health concern in most endemic areas, including Benin. To overcome this, the World Health Organization (WHO) recommends several prevention strategies, including the administration of sulfadoxine-pyrimethamine (SP) during pregnancy. Objective: To study the factors associated with low coverage of Intermittent Preventive Treatment with sulfadoxine-pyrimethamine (IPT-SP) against Malaria in pregnant women at Dassa-Glazoué area hospital in 2020. Study Method: This was a descriptive, analytical study with retrospective data collection that took place from May 25 to September 25, 2020. Results: During our study, three hundred and forty (340) pregnant women were investigated. The mean age was 27.67±6.12 years. The pregnant women included in the study were traders/dealers (35%) with a primary level of education (35%) and living in a common-law relationship (77.65%). The prevalence of IPT-SP coverage in antenatal care (ANC) was 35.00%. The number of ANC (less than 4) attended by the pregnant women (p=0.00), the age of more than 3 months from pregnancy to the first ANC (p=0.00) and non-compliance with ANC (p=0.00) were the factors associated with this low coverage. Conclusion: ANC is a special time for the administration of SP. New strategies must be put into place for the correct use of this service by pregnant women.}, year = {2021} }
TY - JOUR T1 - Factors Associated with Low Coverage of Intermittent Preventive Treatment with Sulfadoxyne-Pyrimethamine in Pregnancy in Dassa-Glazoué AU - Atade Sèdjro Raoul AU - Ogoudjobi Ogourindé Mathieu AU - Dangbemey Djima Patrice AU - Djodi Salamatou AU - Klipezo Roger AU - Salifou Kabibou Y1 - 2021/11/10 PY - 2021 N1 - https://doi.org/10.11648/j.jgo.20210906.12 DO - 10.11648/j.jgo.20210906.12 T2 - Journal of Gynecology and Obstetrics JF - Journal of Gynecology and Obstetrics JO - Journal of Gynecology and Obstetrics SP - 195 EP - 199 PB - Science Publishing Group SN - 2376-7820 UR - https://doi.org/10.11648/j.jgo.20210906.12 AB - Introduction: Malaria during pregnancy is a major public health concern in most endemic areas, including Benin. To overcome this, the World Health Organization (WHO) recommends several prevention strategies, including the administration of sulfadoxine-pyrimethamine (SP) during pregnancy. Objective: To study the factors associated with low coverage of Intermittent Preventive Treatment with sulfadoxine-pyrimethamine (IPT-SP) against Malaria in pregnant women at Dassa-Glazoué area hospital in 2020. Study Method: This was a descriptive, analytical study with retrospective data collection that took place from May 25 to September 25, 2020. Results: During our study, three hundred and forty (340) pregnant women were investigated. The mean age was 27.67±6.12 years. The pregnant women included in the study were traders/dealers (35%) with a primary level of education (35%) and living in a common-law relationship (77.65%). The prevalence of IPT-SP coverage in antenatal care (ANC) was 35.00%. The number of ANC (less than 4) attended by the pregnant women (p=0.00), the age of more than 3 months from pregnancy to the first ANC (p=0.00) and non-compliance with ANC (p=0.00) were the factors associated with this low coverage. Conclusion: ANC is a special time for the administration of SP. New strategies must be put into place for the correct use of this service by pregnant women. VL - 9 IS - 6 ER -